GILD Stock Continues Recovery From Monday’s FallGilead Sciences, Inc. (NASDAQ: GILD)GILD stocks fell hard Monday; losing more than two percent as the company issued a warning to doctors treating their patients with Sovaldi in combination with antiarrhythmics. However, the slide stopped and the stock started to move in the positive direction. Today, it seems as though the stock is staying […]
moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
[at noodls] – Successful Abstral launch in Q4 2013 resulted in $2.5 million in net revenue consistent with guidance of $1.5 to $3 million. Galena is increasing its 2014 Abstral net revenue estimates to $11 to $15 million … moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring […]
moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
[at noodls] – PORTLAND, Ore., March 3, 2014 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major … moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
[at noodls] – PORTLAND, Ore., Feb. 28, 2014 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major … moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
[PR Newswire] – WESTBOROUGH, Mass., Feb. 24, 2014 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII), a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing … moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
[at noodls] – PORTLAND, Ore., Feb. 14, 2014 (GLOBE NEWSWIRE) — Galena Biopharma (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major … moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
moreView todays social media effects on RXIIView the latest stocks trending across Twitter. Click to view dashboardSee who RXi is hiring next, click here to view […]
